Literature DB >> 8478145

Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS.

H R Wabinga1, D M Parkin, F Wabwire-Mangen, J W Mugerwa.   

Abstract

Re-establishment of the cancer registry in Kyadondo County, Uganda, has allowed estimation of incidence rates for the period September 1989 to December 1991. The results are compared with earlier data from the same area, and from other African cancer registries. The most striking feature is the emergence of Kaposi's sarcoma as the leading cancer in males (almost half of all registered cases) and the second most frequent (17.9%) in females. This parallels the evolution of the epidemic of AIDS. There were also marked increases in the incidence of both oesophageal and prostatic carcinoma, while the incidence of cancer of the penis and the urinary bladder declined, possibly as a result of improved standards of hygiene. In females, the incidence of cancer of the cervix has more than doubled since the 1950s, and is now among the highest recorded in the African continent.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Age Factors; Cancer--men; Cancer--women; Data Analysis; Demographic Factors; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Hiv Infections; Incidence; Measurement; Neoplasms; Population; Population Characteristics; Research Methodology; Uganda; Viral Diseases

Mesh:

Year:  1993        PMID: 8478145     DOI: 10.1002/ijc.2910540106

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  72 in total

1.  Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda.

Authors:  Lisa M Butler; Willy A Were; Steven Balinandi; Robert Downing; Sheila Dollard; Torsten B Neilands; Sundeep Gupta; George W Rutherford; Jonathan Mermin
Journal:  J Infect Dis       Date:  2011-01-26       Impact factor: 5.226

Review 2.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

3.  Kaposi sarcoma in calabar, southern Nigeria.

Authors:  Maurice Asuquo; Aniefon Umana; Otei Otei; Imabasi Bassey; Godwin Ebughe
Journal:  Oman Med J       Date:  2009-01

Review 4.  Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings.

Authors:  Aggrey S Semeere; Naftali Busakhala; Jeffrey N Martin
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.645

5.  HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.

Authors:  Sam M Mbulaiteye; Kishor Bhatia; Clement Adebamowo; Annie J Sasco
Journal:  Infect Agent Cancer       Date:  2011-10-17       Impact factor: 2.965

6.  Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.

Authors:  Xuezhong Cai; Shihua Lu; Zhihong Zhang; Carlos M Gonzalez; Blossom Damania; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-30       Impact factor: 11.205

7.  The incidence of oesophageal cancer in Eastern Africa: identification of a new geographic hot spot?

Authors:  Michael L Cheng; Li Zhang; Margaret Borok; Eric Chokunonga; Charles Dzamamala; Anne Korir; Henry R Wabinga; Robert A Hiatt; D Max Parkin; Katherine Van Loon
Journal:  Cancer Epidemiol       Date:  2015-02-03       Impact factor: 2.984

8.  Breast cancer guidelines for Uganda (2nd Edition 2008).

Authors:  A Gakwaya; M Galukande; A Luwaga; J Jombwe; J Fualal; E Kiguli-Malwadde; P Baguma; A Kanyike; J B Kigula-Mugamba
Journal:  Afr Health Sci       Date:  2008-06       Impact factor: 0.927

9.  Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation.

Authors:  Patrick A Carroll; Elizabeth Brazeau; Michael Lagunoff
Journal:  Virology       Date:  2004-10-10       Impact factor: 3.616

Review 10.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.